← FDA Drug Approvals (Drugs@FDA)

TAPENTADOL HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2026-02-10

Drug application

FDA Application #
ANDA205057
Application type
Abbreviated New Drug Application (Generic)
Brand name
TAPENTADOL HYDROCHLORIDE
Generic name
Tapentadol Hydrochloride
Active ingredients
TAPENTADOL HYDROCHLORIDE
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
HIKMA
First approval
2026-02-10

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown